GLP-1 receptor agonists such as semaglutide (Ozempic®, Wegovy®, Rybelsus®) have significantly improved the management of obesity and type 2 diabetes, providing effective weight loss and cardiometabolic benefits. However, as their use becomes more widespread, there has been an increase in...
The COVID-19 pandemic has affected the work of doctors worldwide, with surgical resources being diverted and non-emergency surgeries postponed. With surgical activity at 33.6% of expected levels in 2020, this sudden, vast decrease in surgical activity may have granted some...
We were pleased to have the opportunity to speak to Dr Tristan Mehta, Founder and CEO of Harley Academy, a leading postgraduate training provider of higher education in aesthetic medicine within the UK. Dr Tristan Mehta. What led you to...
“It is an interesting biological fact that all of us have, in our veins the exact same percentage of salt in our blood that exists in the ocean, and, therefore, we have salt in our blood, in our sweat, in...
Acne vulgaris is a common chronic inflammatory skin condition and the eighth most prevalent skin disorder worldwide, with a prevalence of 9.4% [1]. Rosacea is also a common chronic inflammatory skin disorder, with an estimated global prevalence of 5.46% of...
Because of liability issues there is a reluctance to make clinical practice guidelines (CPG) statutory requirements; that is to say, guidelines are ‘suggestions’, not ‘instructions’. And why is this important to this case?
We recently caught up with Dr Uliana Gout, re-elected President of the British College of Aesthetic Medicine (BCAM), about the College’s 20th anniversary year, its plans for 2022 and how it has supported members throughout the pandemic. Are you enjoying...
The author discusses practical guidance for treating the lower face with botulinum toxin. Whilst Abobotulinumtoxin A and Onabotulinumtoxin A are discussed in relation to treating the lower face, Incobotulinum toxin A is not acknowledged, despite the available literature on the...
The latest NHS consultant-led referral-to-treatment data shows that the total waiting list increased by 6,002 in October 2025, reaching 7.3 million. Analysis reveals the percentage of patients who began treatment within 18 weeks slightly decreased to 61.7%, indicating minimal progress...
Patrick Tansley responds to a recent article featured in The PMFA Journal entitled ‘Who should decide the qualification to do cosmetic surgery?’ by Professor James D Frame (with an associated editorial comment by Professor Andrew Burd). When asked to comment...